Teladoc Health (TDOC) 10-K2022 FY Annual report

Filed: 1 Mar 23, 4:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abetting, accrual, ADPPA, Andrew, box, camera, capitalizable, CODM, conditionally, Connecticut, convened, De, draft, ease, edge, elongated, enrichment, ESG, ethnicity, friendly, gap, Hendry, hereof, Hispanic, holiday, Innotech, Inpatient, inquired, inspecting, intersegment, irrespective, Jensen, judgement, Kornwasser, Laizer, Lastly, Leadersel, metric, microphone, modern, nursing, overinvest, predominately, preliminarily, priority, promulgated, quantify, refusal, reorganized, rollforward, sample, Schneider, Schutter, segment, seizure, shareholder, spent, stipulated, suggesting, task, tentative, thereunder, trustee, Turitz, uncovered, underinvest, unfounded, unjust, Utah, Vaughn, verified, vet, Vice, visual, wake, waste, weakest, wider, withdraw, withdrawal

Removed: allocating, called, CEO, combat, commencing, complicated, congestive, consummation, CSF, determinable, diversification, diversified, Forfeiture, forma, Fortune, guaranteed, heart, house, hypertension, implied, macro, netted, orderly, participant, pro, proposal, readily, respiratory, salesforce, separated, study, upper, weight, write

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated TDOC transcripts

TDOC similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Teladoc Health, Inc. (the “Company”) for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jason Gorevic, Chief Executive Officer of the Company, certify, to my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 1, 2023


/s/ JASON GOREVIC
Jason Gorevic
Chief Executive Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.